Endogenous Regulators of the Immune System (sCD100, Malonic Dialdehyde, and Arginase)
- 26 March 2018
- journal article
- review article
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 164 (5) , 693-700
Abstract
Tissue damage in various diseases, hypoxic conditions, and some pathologies are associated with production of endogenous factors such as the soluble form of the surface receptor CD100, malonic dialdehyde, and arginase and their release into circulation. These factors modulate functional state of lymphocytes in the immune system: potentiate activation of B lymphocytes, activate synthesis and secretion of IL-25 and IL-17 cytokines, and suppress proliferative activity of T lymphocytes, thus modulating immunological reactivity of the organism. Reactions of innate and adaptive immunity develop against the background of changed immunological reactivity, which should be taken into account in the development of pathogenetically substantiated therapy.Keywords
This publication has 49 references indexed in Scilit:
- Elevated Plasma Soluble Sema4D/CD100 Levels Are Associated with Disease Severity in Patients of Hemorrhagic Fever with Renal SyndromePLOS ONE, 2013
- RETRACTED ARTICLE: Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progressionAngiogenesis, 2012
- Immune Evasion by Helicobacter pylori Is Mediated by Induction of Macrophage Arginase IIThe Journal of Immunology, 2011
- Diminished contact-dependent reinforcement of Syk activation underlies impaired thrombus growth in mice lacking Semaphorin 4DBlood, 2010
- Semaphorin 4D/Plexin-B1 Stimulates PTEN Activity through R-Ras GTPase-activating Protein Activity, Inducing Growth Cone Collapse in Hippocampal NeuronsJournal of Biological Chemistry, 2010
- L‐Arginine deprivation impairs Leishmania major‐specific T‐cell responsesEuropean Journal of Immunology, 2009
- Disruption of SEMA4D Ameliorates Platelet Hypersensitivity in Dyslipidemia and Confers Protection Against the Development of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Endothelial nitric oxide (NO) and its pathophysiologic regulationVascular Pharmacology, 2008
- Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injuryProceedings of the National Academy of Sciences, 2007
- Sema4D/plexin‐B1 activates GSK‐3β through R‐Ras GAP activity, inducing growth cone collapseEMBO Reports, 2006